Literature DB >> 4367891

The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.

C Y Pak, M Oata, E C Lawrence, W Snyder.   

Abstract

The causes for the hypercalciuria and diagnostic criteria for the various forms of hypercalciuria were sought in 56 patients with hypercalcemia or nephrolithiasis (Ca stones), by a careful assessment of parathyroid function and calcium metabolism. A study protocol for the evaluation of hypercalciuria, based on a constant liquid synthetic diet, was developed. In 26 cases of primary hyperparathyroidism, characteristic features were: hypercalcemia, high urinary cyclic AMP (cAMP, 8.58+/-3.63 SD mumol/g creatinine; normal, 4.02+/-0.70 mumol/g creatinine), high immunoreactive serum parathyroid hormone (PTH), hypercalciuria, the urinary Ca exceeding absorbed Ca from intestinal tract (Ca(A)), high fasting urinary Ca (0.2 mg/mg creatinine or greater), and low bone density by (125)I photon absorption. The results suggest that hypercalciuria is partly secondary to an excessive skeletal resorption (resorptive hypercalciuria). The 22 cases with renal stones had normocalcemia, hypercalciuria, intestinal hyperabsorption of calcium, normal or low serum PTH and urinary cAMP, normal fasting urinary Ca, and normal bone density. Since their Ca(A) exceeded urinary Ca, the hypercalciuria probably resulted from an intestinal hyperabsorption of Ca (absorptive hypercalciuria). The primacy of intestinal Ca hyperabsorption was confirmed by responses to Ca load and deprivation under a metabolic dietary regimen. During a Ca load of 1,700 mg/day, there was an exaggerated increase in the renal excretion of Ca and a suppression of cAMP excretion. The urinary Ca of 453+/-154 SD mg/day was significantly higher than the control group's 211+/-42 mg/day. The urinary cAMP of 2.26+/-0.56 mumol/g creatinine was significantly lower than in the control group. In contrast, when the intestinal absorption of calcium was limited by cellulose phosphate, the hypercalciuria was corrected and the suppressed renal excretion of cAMP returned towards normal. Two cases with renal stones had normocalcemia, hypercalciuria, and high urinary cAMP or serum PTH. Since Ca(A) was less than urinary Ca, the hypercalciuria may have been secondary to an impaired renal tubular reabsorption of Ca (renal hypercalciuria). Six cases with renal stones had normal values of serum Ca, urinary Ca, urinary cAMP, and serum PTH (normocalciuric nephrolithiasis). Their Ca(A) exceeded urinary Ca, and fasting urinary Ca and bone density were normal. The results support the proposed mechanisms for the hypercalciuria and provide reliable diagnostic criteria for the various forms of hypercalciuria.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4367891      PMCID: PMC301566          DOI: 10.1172/JCI107774

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  SECRETION AND EXCRETION OF CALCIUM BY THE HUMAN GASTROINTESTINAL TRACT.

Authors:  R P HEANEY; T G SKILLMAN
Journal:  J Lab Clin Med       Date:  1964-07

2.  Idiopathic hypercaicuria.

Authors:  P H HENNEMAN; P H BENEDICT; A P FORBES; H R DUDLEY
Journal:  N Engl J Med       Date:  1958-10-23       Impact factor: 91.245

3.  Production of hypercalciuria by phosphorus deprivation on a low calcium intake: a new clinical test for hyperparathyroidism.

Authors:  P PRONOVE; N H BELL; F C BARTTER
Journal:  Metabolism       Date:  1961-05       Impact factor: 8.694

4.  Parathyroid function and the renal excretion of 3'5'-adenylic acid.

Authors:  L R Chase; G D Aurbach
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

5.  The interrelationships of calcium and sodium excretions.

Authors:  M R Wills; J R Gill; F C Bartter
Journal:  Clin Sci       Date:  1969-12       Impact factor: 6.124

6.  Normocalcemic primary hyperparathyroidism.

Authors:  M R Wills; C Y Pak; W G Hammond; F C Bartter
Journal:  Am J Med       Date:  1969-09       Impact factor: 4.965

7.  Metabolic and calcium kinetic studies in idiopathic hypercalciuria.

Authors:  U A Liberman; O Sperling; A Atsmon; M Frank; M Modan; A D Vries
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

8.  Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.

Authors:  F L Coe; J M Canterbury; J J Firpo; E Reiss
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

9.  Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.

Authors:  N I Kaminsky; A E Broadus; J G Hardman; D J Jones; J H Ball; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Radioimmunoassay of human parathyroid hormone in serum.

Authors:  C D Arnaud; H S Tsao; T Littledike
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  68 in total

1.  Diagnosis and treatment of primary hyperparathyroidism.

Authors:  M A Dambacher; U Binswanger; J A Fischer
Journal:  Urol Res       Date:  1979-09

2.  Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.

Authors:  J E Zerwekh; K Sakhaee; N A Breslau; F Gottschalk; C Y Pak
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

3.  Reduction of calcium excretion in the stone-forming kidney in unilateral ureteral obstruction.

Authors:  Y H Lee; S S Chang; M T Chen; J K Huang; W C Huang
Journal:  Urol Res       Date:  1991

4.  The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

Authors:  R A Kaplan; M R Haussler; L J Deftos; H Bone; C Y Pak
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

Review 5.  Clinical investigations.

Authors:  F Hering
Journal:  Urol Res       Date:  1990

6.  Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.

Authors:  J W Shaw; S B Oldham; L Rosoff; J E Bethune; M P Fichman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Urinary sodium and calcium in various dog models and relationship to endogenous plasma glucagon.

Authors:  C Bornhof; P O Schwille
Journal:  Urol Res       Date:  1977

8.  Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug.

Authors:  Gerolamo Bianchi; Andrea Giusti; Giulio Pioli; Antonella Barone; Ernesto Palummeri; Giuseppe Girasole
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

9.  Endogenous oestrogen and bone loss following oophorectomy.

Authors:  R Lindsay; D M Hart; A Sweeney; J R Coutts; A Clarke
Journal:  Calcif Tissue Res       Date:  1977-05

10.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.